APA (7th ed.) Citation

GB, J., HY, F., DY, T., XP, C., & FL, C. (2019). COX-2 potentiates cisplatin resistance of non-small cell lung cancer cells by promoting EMT in an AKT signaling pathway-dependent manner. European review for medical and pharmacological sciences, 23(9), 3838. https://doi.org/10.26355/eurrev_201905_17811

Chicago Style (17th ed.) Citation

GB, Jiang, Fang HY, Tao DY, Chen XP, and Cao FL. "COX-2 Potentiates Cisplatin Resistance of Non-small Cell Lung Cancer Cells by Promoting EMT in an AKT Signaling Pathway-dependent Manner." European Review for Medical and Pharmacological Sciences 23, no. 9 (2019): 3838. https://doi.org/10.26355/eurrev_201905_17811.

MLA (9th ed.) Citation

GB, Jiang, et al. "COX-2 Potentiates Cisplatin Resistance of Non-small Cell Lung Cancer Cells by Promoting EMT in an AKT Signaling Pathway-dependent Manner." European Review for Medical and Pharmacological Sciences, vol. 23, no. 9, 2019, p. 3838, https://doi.org/10.26355/eurrev_201905_17811.